Immunome Inc (IMNM)

R&D Expense Growth

29.12%

Quarterly · Period ending:

IMNM logo

IMNM R&D Expense Growth

Latest reported29.12%
IMNM Quarterly R&D Growth (QoQ) (0.00% → 29.12%)
High-resolution chart · PNG

IMNM r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunome Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
29.1154%
-23.6778%
23.5338%
21.6113%
9.7066%
-23.0069%
28.7366%
27.9098%
89.2316%
59.4791%
152.0795%
-33.1176%
46.0772%
-7.9727%
-18.622%
-8.6059%
-29.2275%
84.2189%
-2.8363%
39.5917%
63.3653%
7.8474%
11.618%
-13.1078%
-10.5437%
-13.0345%
8.863%
7.4814%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.